Annual Total Long Term Liabilities
$37.00 K
-$3.07 M-98.81%
December 31, 2023
Summary
- As of February 12, 2025, SPRY annual total long term liabilities is $37.00 thousand, with the most recent change of -$3.07 million (-98.81%) on December 31, 2023.
- During the last 3 years, SPRY annual total long term liabilities has fallen by -$32.21 million (-99.89%).
- SPRY annual total long term liabilities is now -99.96% below its all-time high of $84.53 million, reached on December 31, 2021.
Performance
SPRY Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 12, 2025, SPRY quarterly total long term liabilities is $0.00, unchanged on September 30, 2024.
- Over the past year, SPRY quarterly long term liabilities has stayed the same.
- SPRY quarterly long term liabilities is now -100.00% below its all-time high of $84.53 million, reached on December 1, 2021.
Performance
SPRY Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SPRY Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.8% | 0.0% |
| 3 y3 years | -99.9% | 0.0% |
| 5 y5 years | -99.9% | 0.0% |
SPRY Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
ARS Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) |
| Dec 2023 | $37.00 K | $37.00 K(-59.8%) |
| Sep 2023 | - | $92.00 K(-37.0%) |
| Jun 2023 | - | $146.00 K(-26.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $199.00 K(-93.6%) |
| Dec 2022 | $3.10 M(-96.3%) | $3.10 M(-96.2%) |
| Jun 2022 | - | $82.62 M(-2.3%) |
| Dec 2021 | $84.53 M(+162.1%) | - |
| Dec 2021 | - | $84.53 M |
| Dec 2020 | $32.25 M | - |
FAQ
- What is ARS Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual total long term liabilities year-on-year change?
- What is ARS Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly long term liabilities year-on-year change?
What is ARS Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of SPRY is $37.00 K
What is the all time high annual total long term liabilities for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual total long term liabilities is $84.53 M
What is ARS Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, SPRY annual total long term liabilities has changed by -$3.07 M (-98.81%)
What is ARS Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of SPRY is $0.00
What is the all time high quarterly long term liabilities for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly total long term liabilities is $84.53 M
What is ARS Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, SPRY quarterly total long term liabilities has changed by $0.00 (0.00%)